trifluoperazine has been researched along with Pulmonary Hypertension in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The in vivo therapeutic potential of TFP was tested in two preclinical models with established PAH, namely the monocrotaline and sugen/hypoxia-induced rat models." | 4.02 | Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. ( Awada, C; Bonnet, S; Boucherat, O; Bourgeois, A; Breuils-Bonnet, S; Grobs, Y; Lemay, SE; Nadeau, V; Orcholski, M; Paulin, R; Provencher, S; Romanet, C; Shimauchi, K; Toro, V; Tremblay, E, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grobs, Y | 1 |
| Awada, C | 1 |
| Lemay, SE | 1 |
| Romanet, C | 1 |
| Bourgeois, A | 1 |
| Toro, V | 1 |
| Nadeau, V | 1 |
| Shimauchi, K | 1 |
| Orcholski, M | 1 |
| Breuils-Bonnet, S | 1 |
| Tremblay, E | 1 |
| Provencher, S | 1 |
| Paulin, R | 1 |
| Boucherat, O | 1 |
| Bonnet, S | 1 |
| Seeger, W | 1 |
| Bauer, M | 1 |
| Bhakdi, S | 1 |
2 other studies available for trifluoperazine and Pulmonary Hypertension
| Article | Year |
|---|---|
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
Topics: Animals; Antipsychotic Agents; Cardiovascular Agents; Cell Proliferation; Disease Models, Animal; Dr | 2021 |
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bacterial Toxins; Blood Pressure; Calcimycin; Calcium; | 1984 |